SCHEMBL16166372

SCHEMBL16166372

CC(c1ccc(Cl)cc1)n1nncc1N

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.41
CYP19A1 P11511 4/20 0.40
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.36
CLK1 P49759 1/20 0.36
DYRK1A Q13627 1/20 0.36
GAA P10253 1/20 0.34
GFER P55789 1/20 0.34
CYP11B1 P15538 4/20 0.33
CYP11B2 P19099 4/20 0.33
RXFP1 Q9HBX9 1/20 0.33
USP2 O75604 1/20 0.33
TP53 P04637 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP3A4 P08684 2/20 0.32
SIGMAR1 Q99720 1/20 0.32
IDO1 P14902 1/20 0.32
TDO2 P48775 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16166590 1.00 ADRB2 (0.41) ADRB2CYP19A1ALDH1A1HTTCLK1
SCHEMBL16166877 1.00 ADRB2 (0.41) ADRB2CYP19A1ALDH1A1HTTCLK1
SCHEMBL25064763 0.83
SCHEMBL16166240 0.80 PDE2A (0.44)
SCHEMBL16175847 0.70 ALDH1A1 (0.42) ADRB2CYP19A1ALDH1A1CYP11B1CYP11B2
SCHEMBL16166256 0.67 HPGD (0.43) ADRB2HTTCLK1DYRK1AGAA
SCHEMBL17560901 0.66 ADRB2 (0.48) ADRB2CYP19A1CYP11B1CYP11B2TP53
SCHEMBL29788850 0.66 CYP19A1 (0.48) ADRB2CYP19A1ALDH1A1GAA
SCHEMBL16166445 0.63 GAA (0.56) CYP19A1ALDH1A1HTTGAAGFER
SCHEMBL197810 0.61 ADRB2 (0.65) ADRB2CYP19A1HTTTP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014167528-A1 SPIROPYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF VIRAL INFECTIONS NOVARTIS AG (CH) 2014-10-16 WO disclosed
WO-2014167528-A1 SPIROPYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF VIRAL INFECTIONS NOVARTIS AG (CH) 2014-10-16 WO disclosed